Julie Johnson
Julie Johnson (D-TX) sold $1K-$15K of $MMM (3M Company Common Stock (MMM)) on Nov 13, 2025, part of 63 transactions in this filing.
HillSignal flagged 5 timing concerns on this filing — trades that line up closely with related legislative or contract activity.
Price Movement Since Trade
How the largest positions have moved from the trade date to the most recent close.
Showing the 6 largest positions. See every transaction in the table below.
Suspicious Timing Detected
5 flagsRep. Julie Johnson sold $1,001 - $15,000 in $ADBE on November 3, 2025 — 2 days before the AI-Related Job Impacts Clarity Act (S3108) was introduced, a bill potentially increasing compliance burdens for tech companies.
Rep. Julie Johnson sold $1,001 - $15,000 in $EOG on November 13, 2025 — 5 days before the CLEANER Act of 2025 (HR6080) was introduced, which could increase disposal costs for oil and gas companies.
Rep. Julie Johnson sold $1,001 - $15,000 in $LLY, JNJ, and MRK on November 13, 2025 — 7 days before the Lowering Drug Costs for American Families Act (HR6166) was introduced, a bill that could reduce pharmaceutical company revenues.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| PARTIAL SELL | $MMM | 3M Company Common Stock (MMM) | $1K-$15K | — | — | — | Nov 13, 2025 |
| PARTIAL SELL | $ABT | Abbott Laboratories Common Stock (ABT) | $1K-$15K | $129.26 | — | — | Nov 13, 2025 |
| PARTIAL SELL | $ABBV | AbbVie Inc. Common Stock (ABBV) | $1K-$15K | $232.29 | $205.12 | -11.7% | Nov 13, 2025 |
| SELL | $ADBE | Adobe Inc. - Common Stock (ADBE) | $1K-$15K | $337.47 | $247.18 | -26.8% | Nov 3, 2025 |
| PARTIAL SELL | $APD | Air Products and Chemicals, Inc. Common Stock (APD) | $1K-$15K | $263.03 | — | — | Nov 13, 2025 |
| PARTIAL SELL | $GOOG | Alphabet Inc. - Class C Capital Stock (GOOG) | $1K-$15K | $279.12 | — | — | Nov 13, 2025 |
| PARTIAL SELL | $AXP | American Express Company Common Stock (AXP) | $1K-$15K | $364.73 | — | — | Nov 13, 2025 |
| PARTIAL SELL | $ADI | Analog Devices, Inc. - Common Stock (ADI) | $1K-$15K | $237.53 | — | — | Nov 13, 2025 |
| PARTIAL SELL | $AJG | Arthur J. Gallagher & Co. Common Stock (AJG) | $1K-$15K | $256.71 | — | — | Nov 13, 2025 |
| PARTIAL SELL | $BAC | Bank of America Corporation Common Stock (BAC) | $1K-$15K | $52.87 | $53.48 | +1.2% | Nov 13, 2025 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
CLOSE Act
The CLOSE Act (HR6081) is an early-stage House bill that would eliminate the emission aggregation exemption for oil and gas wells under the Clean Air Act and require EPA to list hydrogen sulfide as a hazardous air pollutant. While the bill has 23 Democratic cosponsors and faces a long legislative path, it creates a regulatory overhang for U.S. E&P operators. Recent DPA energy executive orders (April 2026) conflict with the bill's direction, adding policy uncertainty.
Lowering Drug Costs for American Families Act
The Lowering Drug Costs for American Families Act (HR6166) expands Medicare drug negotiation from 20 to 50 drugs and extends inflation rebates to commercial markets, targeting bearish revenue compression for major pharma ($MRK, $PFE, $LLY). Health insurers ($UNH, $CVS) face mixed effects — lower drug costs offset by new out-of-pocket caps. The bill is in early committee stage, giving markets time to price in the structural shift.
Foreign Robocall Elimination Act
The Foreign Robocall Elimination Act (HR6152) is an early-stage bill that establishes an interagency taskforce to study unlawful robocalls. It authorizes zero funding, imposes no compliance costs or mandates on telecom carriers, and remains in committee with no near-term market impact.
HEAR Act of 2025
The HEAR Act of 2025 is an early-stage, unfunded bill with no Senate companion, no committee hearing, and no markup. It proposes Medicare coverage for hearing aids, which would expand the total addressable market for hearing health, but no publicly traded pure-play hearing aid companies are represented in the provided ticker list. The bill has zero legislative momentum and zero appropriated funding, making it a non-event for current market pricing.
AI-Related Job Impacts Clarity Act
The AI-Related Job Impacts Clarity Act (S3108) is an early-stage Senate bill requiring quarterly disclosures of AI-driven job changes. It imposes new compliance costs on major AI investors like Microsoft, Alphabet, Amazon, NVIDIA, and Meta without allocating any funding. Market impact is currently low given the bill's procedural status, but the transparency risk is real for AI-heavy companies.
ERISA Litigation Reform Act
HR6084, the ERISA Litigation Reform Act, has cleared the House Education & Workforce Committee on a party-line 19-13 vote and awaits floor action. The bill imposes a mandatory discovery stay during motions to dismiss and heightens pleading standards for ERISA fiduciary lawsuits, directly reducing legal costs and liability exposure for major financial institutions serving as retirement plan fiduciaries. BlackRock ($BLK), Charles Schwab ($SCHW), Morgan Stanley ($MS), JPMorgan Chase ($JPM), and Bank of America ($BAC) are the primary beneficiaries.
Baby Bonus Act
The Baby Bonus Act (HR6234) has been stuck in the House Ways and Means Committee for over five months with no appropriations and no cosponsors from committee leadership. It has zero current or near-term market impact. No tickers meet confidence thresholds for inclusion.
CLEANER Act of 2025
The CLEANER Act (HR6080) proposes reclassifying oil/gas drilling wastes as hazardous, directly increasing operating costs for US E&P companies like $XOM, $CVX, and $EOG while creating a new revenue stream for waste management firms $WM and $RSG. The bill is in early committee stage with 23 Democratic cosponsors — low probability of passage in the 119th Congress given Republican control, but the fundamental mechanism creates clear winners and losers. Recent market action shows energy stocks recovering from 30-day losses: $XOM at $154.67 (up 2.75% 7-day), $CVX at $192.22 (+2.46%), $EOG at $139.12 (+3.92%) — but the regulatory overhang, if this bill advances, would reverse that trend for producers.
Improve and Enhance the Work Opportunity Tax Credit Act
The 'Improve and Enhance the Work Opportunity Tax Credit Act' (S3265) proposes to double the maximum WOTC from $2,400 to $6,000 per eligible hire and extend the program through 2030. Staffing firms ($KFRC, $MAN, $RHI) and high-turnover employers ($TGT, $WMT, $MCD, $SBUX) are structurally positioned to benefit from reduced labor costs. Kforce Inc. has already priced in significant momentum, surging +58.37% in the last 30 days to $46.72, approaching its 52-week high.
Revitalize Our Neighborhoods Act of 2025
The Revitalize Our Neighborhoods Act (HR6217) is an early-stage bill authorizing HUD competitive grants for blight elimination and neighborhood revitalization. It has zero funded dollars, is stuck in committee since November 2025, and presents no near-term market catalyst for homebuilders ($LEN, $DHI, $PHM) or retailers ($HD, $LOW). Real market data shows all five tickers have declined 2-4% in the past week, consistent with sector headwinds, not legislative activity.
Other Filings by Julie Johnson
Free — no credit card
Get the next Johnson trade the day it's disclosed
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.